maprotiline has been researched along with Fatty Liver in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, H | 1 |
| Furusato, M | 1 |
| Takasaki, S | 1 |
| Watanabe, M | 1 |
| Hattori, Y | 1 |
1 other study available for maprotiline and Fatty Liver
| Article | Year |
|---|---|
Morphological and biochemical alteration in the rat liver induced by maprotiline.
Topics: Aminopyrine N-Demethylase; Animals; Anthracenes; Antidepressive Agents; Castration; Cytochrome P-450 | 1975 |